Healthcare - Biotechnology - NASDAQ - US
$ 0.754
0.533 %
$ 29.8 M
Market Cap
-1.57
P/E
INCOME STATEMENT
0
REVENUE
-22.9 M
OPERATING INCOME
-22.5 M
NET INCOME
EFFICIENCY
Earnings Waterfall
MiNK Therapeutics, Inc.
| Revenue | 0 |
| Cost Of Revenue | 205 K |
| Gross Profit | -205 K |
| Operating Expenses | 22.9 M |
| Operating Income | -22.9 M |
| Other Expenses | -463 K |
| Net Income | -22.5 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 0 | 2 704.7 | 0 | 0 | 0.7 |
| GROSS PROFIT | |||||
| Cost Of Revenue | 0.2 | 30 949.3 | 28 358.6 | 55.1 K | 0 |
| Gross Profit | (0.2) | (28 244.5) | (28 358.6) | 55.1 K | 0.7 |
| OPERATING INCOME | |||||
| Operating Expenses | 22.9 | 30.9 | 18.6 | 10.8 | 23.5 |
| Selling, General and Administrative Expenses | 7.4 | 7.8 | 4.6 | 1.3 | 3.8 |
| Research and Development Expenses | 15.5 | 23.1 | 14.0 | 9.5 | 19.7 |
| Operating Income | (22.9) | (30.9) | (28.4) | (14.6) | (22.3) |
| PRE-TAX INCOME | |||||
| Interest Income Expense | 0 | 0.3 | 2.4 | 2.4 | 1.6 |
| Total Other Income | 0.5 | 3.0 | (1.9) | (1.6) | (1.5) |
| Pre-Tax Income | (22.5) | (28.0) | (30.2) | (16.2) | (23.8) |
| NET INCOME | |||||
| Tax Provision | 0 | (3.2) | (7.1) | (0.6) | 2.1 |
| Net Income | (22.5) | (24.8) | (23.1) | (15.7) | (25.9) |
| EPS | 0.65 | 0.74 | 0.69 | 0.47 | 0.78 |